Abstract
The excitatory amino acids (EAA) glutamate (Glu) and aspartate (Asp) are now recognized as key participants in a variety of physiologic and pathologic processes. On the one hand, these agents are likely to function as neurotransmitters at the majority of fast excitatory synapses in the vertebrate central nervous system (CNS), playing roles in normal synaptic transmission (Collingridge and Lester, 1989; Mayer and Westbrook, 1987a) and several forms of synaptic plasticity (Kuba and Kumamoto, 1990). Yet exposure of neurons to these agents clearly has toxic consequences, prompting hypotheses regarding the involvement of EAA in human neuro-degenerative syndromes (Olney, 1990). In this chapter we will review evidence linking EAA to specific neuropsychiatric syndromes.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Albin RL, Young AB, Penney, JB (1989): The functional anatomy of basal ganglia disorders. Trends Neurosci 12: 366–375
Arendash GW, Millard WJ, Dunn AJ, Meyer EM (1987): Long-term neuropathological and neurochemical effects of nucleus basalis lesions in the rat. Science 238: 952–956
Auer RN, Kalimo H, Olsson Y, Wieloch T (1985): The dentate gyrus in hypoglycemia. Pathology implicating excitotoxin-induced neuronal necrosis. Acta Neuropathol 67: 279–288
Bartus RT, Dean RC, Beer B, Lippa AS (1982): Cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408–417
Beal MF, Kowall NW, Ellison DW, Mazurek MF, Swartz KJ (1986): Replication of the neurochemical characteristics of Huntington’s disease by quinolinic acid. Nature 321: 168–171
Bear MF, Cooper LN, Ebner FF (1987): A physiological basis for a theory of synapse modification. Science 237: 42–48
Benveniste H, Drejer J, Schousboe A, Diemer NM (1984): Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43: 1369–1374
Berridge MJ (1987): Inositol trisphosphate and diacyglycerol: Two interacting second messengers. Annu Rev Biochem 56: 159–193
Boulter J, Hollmann M, O’Shea-Greenfield A, Hartley M, Deneris E, Maron C, Heinemann S (1990): Molecular cloning and functional expression of glutamate receptor subunit genes. Science 249: 1033–1037
Bridges RJ, Stevens DR, Kahle JS, Nunn PB, Kadri M, Cotman CW (1989): Structure-function studies on N-oxalyl-diamino-dicarboxylic acids and excitatory amino acid receptors: Evidence that 3-L-ODAP is a selective non-NMDA agonist. J Neurosci 9: 2073–2079
Choi DW (1987): Ionic dependence of glutamate neurotoxicity. J Neurosci 7: 369–379
Choi DW (1988): Glutamate neurotoxicity and diseases of the nervous system. Neuron 1: 623–634
Choi DW (1990): Cerebral hypoxia: Some new approaches and unanswered questions. J Neurosci 10:2493–2501
Choi DW, Maulucci-Gedde M, Kriegstein AR (1987): Glutamate neurotoxicity in cortical cell culture. J Neurosci 7: 357–368
Clifford DB, Olney JW, Benz AM, Fuller TA, Zorumski CF (1990): Ketamine, phencyclidine and MK-801 protect against kainic acid induced seizure-related brain damage. Epilepsia 31: 382–390
Clifford DB, Zorumski CF, Olney JW (1989): Ketamine and MK-801 prevent degeneration of thalamic neurons induced by focal cortical seizures. Exp Neurol 105: 272–279
Collingridge GL, Lester RAJ (1989): Excitatory amino acid receptors in the vertebrate central nervous system. Pharm Rev 40: 143–210
Collins RC, Olney JW (1982): Focal cortical seizures cause distant thalamic lesions. Science 218: 177–179
Copani A, Canonico PL, Nicoletti F (1990): 13-N-Methylamino-L-alanine (L-BMAA) is a potent agonist of metabolotropic glutamate receptors. Eur J Pharmacol 181: 327–328
Cotman CW, Flatman JA, Ganong AH, Perkins MN (1986): Effects of excitatory amino acid antagonists on evoked and spontaneous excitatory potentials in guinea pig hippocampus. J Physiol (Lond) 378: 403–415
Coyle JT, McGeer EF, McGeer PL, Schwarcz R (1978): Neostriatal injections: A model for Huntington’s chorea. In: Kainic Acid as a Tool in Neurobiology, McGeer E, Olney JW, McGeer P, eds. New York: Raven Press, pp 139–159
Coyle JT, Price DL, DeLong MA (1983): Alzheimer’s disease: A disorder of cortical cholinergic innervation. Science 219: 1184–1190
Curtis DR, Watkins JC (1960): The excitation and depression of spinal neurons by structurally related amino acids. J Neurochem 6: 117–141
DeBoni U, McLachlan DRC (1985): Controlled induction of paired helical filaments of the Alzheimer type in cultured human neurons by glutamate and aspartate. J Neurol Sci 68: 105–118
Faden AI, Demediuk P, Panter S, Vink R (1989): The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244: 798–800
Foster AC, Fagg GE (1984): Acidic amino acid binding sites in mammalian neuronal membranes: Their characteristics and relationship to synaptic receptors. Brain Res Rev 7: 103–164
Gay VL, Plant TM (1987): N-Methyl-D-aspartate elicits hypothalamic gonadotropinreleasing hormone release in prepubertal male rhesus monkeys (Macaca mulatta). Endocrinology 120: 2289–2296
Heafield MT, Fearn S, Steventon GB, Waring RH, Williams AD, Sturman SG (1990): Plasma cysteine and sulfate levels in patients with motor neurone, Parkinson’s and Alzheimer’s disease. Neurosci Lett 110: 216–220
Honoré T, Davies SN, Drejer J, Fletcher EJ, Jacobsen P, Lodge D, Nielsen FE (1988): Quinoxalinediones: Potent competitive non-NMDA glutamate receptor antagonists. Science 241: 701–703
Ikonomidou C, Price MT, Mosinger JL, Friedrich G, Labruyere J, Salles KS, Olney JW (1989): Hypobaric-ischemic conditions produce glutamate-like cytopathology in infant rat brain. J Neurosci 9: 1693–1700
Johnson JW, Ascher P (1987): Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 325: 529–531
Katayama Y, Cheung MK, Gorman L, Tamura T, Becker DP (1988): Increase in extracellular glutamate and associated massive ionic fluxes following concussive brain injury. Neurosci Abstr 14: 1154
Charles F. Zorumski and John W. Olney
Keinanen K, Wisden W, Sommer B, Werner P, Herb A, Verdoorn TA, Sakmann B, Seeburg PH (1990): A family of AMPA-selective glutamate receptors. Science 249: 556–560
Koh JY, Goldberg MP, Hartley DM, Choi DW (1990): Non-NMDA receptor-mediated neurotoxicity in cortical culture. J Neurosci 10: 693–705
Kuba K, Kumamoto E (1990): Long-term potentiation in vertebrate synapses: A variety of cascades with common subprocesses. Prog Neurobiol 34: 197–269
Lothman EW, Collins RC (1981): Kainic acid induced limbic seizures: Metabolic, behavioral, electroencephalographic and neuropathological correlates. Brain Res 218: 299–318
Lucas DR, Newhouse JP (1957): The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol 58: 193–201
Maragos WF, Greenamyre JT, Penney JB, Young AB (1987): Glutamate dysfunc-tion in Alzheimer’s disease: An hypothesis. Trends Neurosci 10: 65–68
Mattson MP, Dou P, Kater SB (1988): Outgrowth regulating actions of glutamate in isolated hippocampal pyramidal neurons. J Neurosci 8: 2087–2100
Mayer ML, Westbrook GL (1984): Mixed agonist action on excitatory amino acids on mouse spinal cord neurons under voltage-clamp. J Physiol (Lond) 354: 29–53
Mayer ML, Westbrook GL, Guthrie PB (1984): Voltage-dependent block by Mg’ of NMDA responses in spinal cord neurons. Nature 309: 261–263
Mayer ML, Westbrook GL (1987a). The physiology of excitatory amino acids in the vertebrate central nervous system. Prog Neurobiol 28: 197–276
Mayer ML, Westbrook GL (1987b). Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurones. J Physiol (Lond) 394: 501–527
Miller R, Slaughter M (1986): Excitatory amino acid receptors of the retina: Diversity of subtypes and conductance mechanisms. Trends Neurosci 9: 211–218
Monaghan DT, Bridges RJ, Cotman CW (1989): The excitatory amino acid receptors: Their classes, pharmacology and distinct properties in the function of the central nervous system. Annu Rev Pharmacol Toxico! 29: 365–402
Mudd SH, Irreverre F, Laster L (1967): Sulfite oxidase deficiency in man: Demonstration of the enzyme defect. Science 156: 1599–1602
Nunn PB, Davis AJ, O’Brien P (1991): On carbamate formation and the neurotoxicity of L-a-amino acids. Science 251: 1619–1620
Olney JW (1969a): Glutamate-induced retinal degeneration in neonatal mice: Electron microscopy of the acutely evolving lesion. J Neuropathol Exp Neurol 28: 455–474
Olney JW (1969b): Brain lesions, obesity and other disturbances in mice treated with monosodium glutamate. Science 164: 719–721
Olney JW (1971): Glutamate-induced neuronal necrosis in the infant mouse hypothalamus: An electron microscopic study. J Neuropathol Exp Neurol 30: 75–90
Olney JW (1979): Excitotoxic amino acids and Huntington’s disease. Advan Neurol (Huntington’s Disease) 23: 609–624
Olney JW (1990): Excitotoxic amino acids and neuropsychiatric disorders. Annu Rev Pharmacol Toxicol 30: 47–71
Olney JW, DeGubareff T, Sloviter RS (1983): Epileptic brain damage in rats induced by sustained electrical stimulation of the perforant path. II. Ultrastructural analysis of acute hippocampal pathology. Brain Res Bull 10: 699–712
Olney JW, Ho OL, Rhee V (1971): Cytotoxic effects of acidic and sulphur-containing amino acids on the infant mouse central nervous system. Exp Brain Res 14: 61–76
Olney JW, Ho OL, Rhee V, Schainker B (1972a): Cysteine induced brain damage in infant and fetal rodents. Brain Res 45: 309–313
Olney JW, Labruyere J, deGubareff T (1980): Brain damage in mice from voluntary ingestion of glutamate and aspartate. Neurobehav Toxico! 2: 135–129
Olney JW, Labruyere J, Price MT (1989): Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science 244: 1360–1362
Olney JW, Misra CH, deGubareff T (1975): Cysteine-S-sulfate: A brain damaging metabolite in sulfite oxidase deficiency. J Neuropathol Exp Neurol 34: 167–176
Olney JW, Misra CH, Rhee V (1976): Brain and retinal damage from the lathyrus excitotoxin, (3-N-oxalyl-L-a,ß-diaminopropionic acid (ODAP). Nature 264: 659–661
Olney JW, Price MT (1980): Neuroendocrine interactions of excitatory and inhibitory amino acids. Brain Res Bull 5 (Suppl 2): 361–368
Olney JW, Price MT, Samson L, Labruyere J (1986): The role of specific ions in glutamate neurotoxicity. Neurosci Lett 65: 65–71
Olney JW, Sharpe LG, Feigin RD (1972b): Glutamate induced brain damage in infant primates. J Neuropathol Exp Neurol 31: 464–488
Olney JW, Zorumski C, Price MT, Labruyere J (1990a): L-Cysteine, a bicarbonate sensitive endogenous excitotoxin. Science 248: 596–599
Olney JW, Zorumski CF, Stewart GR, Price MT, Wang G, Labruyere J (1990b): Excitotoxicity of L-DOPA and 6-OH-DOPA: Implications for Parkinson’s and Huntington’s diseases. Exp Neurol 108: 269–272
Perl TM, Bedard L, Kosatsky T, Hockin JC, Todd ECD, Remis RS (1990): An outbreak of toxic encephalopathy caused by eating mussels contaminated with domoic acid. New Engl JMed 322: 1775–1780
Plaitakis A, Berl S, Yahr M (1984): Neurological disorders associated with deficiency of glutamate dehydrogenase. Ann Neuro! 15: 144–153
Plaitakis A, Caroscio JT (1987): Abnormal glutamate metabolism in amyotrophic lateral sclerosis. Ann Neuro! 22: 575–579
Plant TM, Gay VL, Marshall GR, Arslan M (1989): Puberty in monkeys is triggered by chemical stimulation of the hypothalamus. Proc Natl Acad Sci USA 86: 2506–2510
Price MT, Olney JW, Anglim M, Buchsbaum S (1979): Reversible action of N-methyl aspartate on gonadotropin neuroregulation. Brain Res 176: 165–168
Procter AW, Palmer AM, Frances PT, Lowe SL, Neary D, Murphy E, Doshi R, Bowen DM (1988): Evidence of glutamatergic denervation and possible abnormal metabolism in Alzheimer’s disease. J Neurochem 50: 790–802
Reynolds GP, Pearson SJ, Halket J, Sandler M (1988): Brain quinolinic acid in Huntington’s disease. J Neurochem 50: 1959–1960
Ross SM, Roy DN, Spencer PS (1989): ß-N-Oxalylamino-L-alanine action on glutamate receptors. J Neurochem 53: 710–715
Rothman SM (1984): Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neurosci 4: 1884–1891
Rothman SM (1985): The neurotoxicity of excitatory amino acids is by passive chloride influx. J Neurosci 5: 1483–1489
Rothstein JD, Tsai G, Kund RW, Clawson L, Cornblath DR, Drachman DB, Pestronk A, Stauch BL, Coyle JT (1990): Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neuro! 28: 18–25
Schwarcz R, Kohler C (1983): Differential vulnerability of central neurons of the rat to quinolinic acid. Neurosci Lett 38: 85–90
Simon RP, Swan JH, Griffiths T, Meldrum BS (1984): Blockade of N-methyl-Daspartate receptors may protect against ischemic damage in the brain. Science 226: 850–852
Slevin JT, Collins JF, Coyle JT (1983): Analogue interactions with the brain receptor labeled by [3H]kainic acid. Brain Res 265: 169–172
Sofroniew MV, Pearson RCA (1985): Degeneration of cholinergic neurons in the basal nucleus following kainic or N-methyl-D-aspartic acid application to the cerebral cortex in the rat. Brain Res 339: 186–190
Sommer B, Keinanen K, Verdoorn TA, Wisden W, Burnashev N, Herb A, Kohler M, Takagi T, Sakmann B, Seeburg PH (1990): Flip and flop. A cell specific functional switch in glutamate operated channels of the CNS. Science 249: 1580–1585
Spencer PS, Allen RG, Kisby GE, Ludolph AC (1990): Excitotoxic disorders. Science 248: 144
Spencer PS, Ludolph A, Dwivedi MP, Roy DN, Hugon J, Schaumbure HH (1986): Lathyrism: Evidence for a role of the neuroexcitatory amino acid BOAA. Lancet 2: 1066–1067
Spencer PS, Nunn PB, Hugon J, Ludolph AC, Ross SM, Roy DN, Robertson RC (1987): Guam amyotrophic lateral sclerosis-Parkinsonism-dementia linked to a plant excitant neurotoxin. Science 237: 517–522
Sprosen TS, Woodruff GN (1990): Polyamines potentiate NMDA induced whole cell currents in cultured striatal neurons. Eur J Pharmacol 179: 477–478
Stewart GR, Zorumski CF, Price MT, Olney JW (1990): Domoic acid: A dementia-inducing excitotoxic food poison with kainic acid receptor specificity. Exp Neurol 110: 127–138
Tecoma ES, Monyer H, Goldberg MP, Choi DW (1989): Traumatic neuronal injury in vitro is attenuated by NMDA antagonists. Neuron 2: 1541–1545
Teitelbaum JS, Zatorre RJ, Carpenter S, Gendron D, Evans AC, Gjedde A, Cashman NR (1990): Neurologic sequelae of domoic acid intoxication due to the ingestion of contaminated mussels. New Engl J Med 322: 1781–1787
Trussell LO, Thio LL, Zorumski CF, Fischbach GD (1988): Rapid desensitization of glutamate receptors in vertebrate central neurons. Proc Natl Acad Sci USA 85: 2834–2838
Urbanski HF, Ojeda SR (1990): A role for N-methyl-D-aspartate (NMDA) receptors in the control of LH secretion and initiation of female puberty. Endocrinology 126: 1774–1776
Watkins JC, Krogsgaard-Larsen P, Honoré T (1990): Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists. Trends Pharmacol Sci 11: 25–33
Weiss JH, Choi DW (1988): Beta-N-Methylamino-L-alanine neurotoxicity: Requirement for bicarbonate as a cofactor. Science 241: 973–975
Weiss JH, Hartley DM, Koh J, Choi DW (1990): The calcium channel blocker nifedipine attenuates slow excitatory amino acid neurotoxicity. Science 247: 1474–1477
Weiss JH, Koh JY, Choi DW (1989): Neurotoxicity of 13-N-methylamino-L-alanine (BMAA) and ß-N-oxalylamino-L-alanine (BOAA) on cultured cortical neurons. Brain Res 497: 64–71
Westbrook GL, Mayer ML (1987): Micromolar concentrations of Zn’ antagonize NMDA and GABA responses of hippocampal neurons. Nature 328: 640–643
Wieloch T (1985): Hypoglycemia induced neuronal damage prevented by an N-methyl-D-aspartate antagonist. Science 230: 681–683
Wieloch T, Engelsen B, Westerberg E, Auer R (1985): Lesions of the glutamatergic cortico-striatal projection in the rat ameliorate hypoglycemic brain damage in the striatum. Neurosci Lett 58: 25–30
Zorumski CF, Thio LL, Clark GD, Clifford DB (1990): Blockade of desensitization augments quisqualate excitotoxicity in hippocampal neurons. Neuron 5: 61–66
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1992 Birkhäuser Boston
About this chapter
Cite this chapter
Zorumski, C.F., Olney, J.W. (1992). Excitotoxicity and Neurodegenerative Disorders. In: Marangos, P.J., Lal, H. (eds) Emerging Strategies in Neuroprotection. Advances in Neuroprotection, vol 22. Birkhäuser, Boston, MA. https://doi.org/10.1007/978-1-4684-6796-3_17
Download citation
DOI: https://doi.org/10.1007/978-1-4684-6796-3_17
Published:
Publisher Name: Birkhäuser, Boston, MA
Print ISBN: 978-1-4684-6798-7
Online ISBN: 978-1-4684-6796-3
eBook Packages: Springer Book Archive